What does make an amyloid toxic: morphology, structure or interaction with membrane?

The toxicity of amyloids is a subject under intense scrutiny. Many studies link this toxicity to the existence of various intermediate structures prior to the fiber formation and/or their specific interaction with membranes. Membranes can also be a catalyst of amyloidogenesis and the composition or the charge of membrane lipids may be of particular importance. Despite intensive research in the field, such intermediates are not yet fully characterized probably because of the lack of adapted methods for their analyses, and the mechanisms of interaction with the membrane are far to be understood. The purpose of this mini-review is to highlight some in vitro characteristics that seem to be convergent to explain the toxicity observed for some amyloids. Based on a comparison between the behavior of a model non-toxic amyloid (the Prion Forming Domain of HET-s) and its toxic mutant (M8), we could establish that short oligomers and/or fibers assembled in antiparallel β-sheets strongly interact with membrane leading to its disruption. Many recent evidences are in favor of the formation of antiparallel toxic oligomers assembled in β-helices able to form pores. We may also propose a new model of amyloid interaction with membranes by a "raft-like" mode of insertion that could explain important destabilization of membranes and thus amyloid toxicity.

[1]  C. Dobson,et al.  Characterization of oligomeric species on the aggregation pathway of human lysozyme. , 2009, Journal of molecular biology.

[2]  Kyle L. Morris,et al.  X-ray fibre diffraction studies of amyloid fibrils. , 2012, Methods in molecular biology.

[3]  Susan Lindquist,et al.  Prions, protein homeostasis, and phenotypic diversity. , 2010, Trends in cell biology.

[4]  L. Servant,et al.  Comparative studies of nontoxic and toxic amyloids interacting with membrane models at the air-water interface. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[5]  V. Coustou,et al.  The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  S. Ji,et al.  Intra-membrane Oligomerization and Extra-membrane Oligomerization of Amyloid-β Peptide Are Competing Processes as a Result of Distinct Patterns of Motif Interplay* , 2011, The Journal of Biological Chemistry.

[7]  R. Sabaté,et al.  Spontaneous incorporation of β-amyloid peptide into neutral liposomes , 2005 .

[8]  K. Reymann,et al.  Mechanism of amyloid plaque formation suggests an intracellular basis of Aβ pathogenicity , 2010, Proceedings of the National Academy of Sciences.

[9]  Brice Kauffmann,et al.  Driving amyloid toxicity in a yeast model by structural changes: a molecular approach , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  David Eisenberg,et al.  Atomic View of a Toxic Amyloid Small Oligomer , 2012, Science.

[11]  H. Scheraga,et al.  Structure of beta-sheets. Origin of the right-handed twist and of the increased stability of antiparallel over parallel sheets. , 1982, Journal of molecular biology.

[12]  Heather T. McFarlane,et al.  Atomic structures of amyloid cross-β spines reveal varied steric zippers , 2007, Nature.

[13]  Thomas L. Williams,et al.  Membrane and surface interactions of Alzheimer’s Aβ peptide – insights into the mechanism of cytotoxicity , 2011, The FEBS journal.

[14]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.

[15]  Maarten F. M. Engel,et al.  Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane , 2008, Proceedings of the National Academy of Sciences.

[16]  G. Bitan,et al.  Neurotoxic protein oligomers — what you see is not always what you get , 2005, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[17]  Eric J. Simon,et al.  Structural model for the β-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide , 1995, Nature Structural Biology.

[18]  Chen Zhang,et al.  Amyloid-Like Aggregates of the Yeast Prion Protein Ure2 Enter Vertebrate Cells by Specific Endocytotic Pathways and Induce Apoptosis , 2010, PloS one.

[19]  Richard D. Leapman,et al.  Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils , 2005, Science.

[20]  S. Radford,et al.  Fibril Fragmentation Enhances Amyloid Cytotoxicity*♦ , 2009, The Journal of Biological Chemistry.

[21]  A. Miranker,et al.  Phospholipid catalysis of diabetic amyloid assembly. , 2004, Journal of molecular biology.

[22]  A. Cedazo-Mínguez,et al.  Influence of residue 22 on the folding, aggregation profile, and toxicity of the Alzheimer's amyloid beta peptide. , 2009, Biophysical journal.

[23]  Jeff Kuret,et al.  Rapid Anionic Micelle-mediated α-Synuclein Fibrillization in Vitro* , 2003, Journal of Biological Chemistry.

[24]  Howard Schulman,et al.  Global changes to the ubiquitin system in Huntington's disease , 2007, Nature.

[25]  C. Marchal,et al.  The toxicity of an “artificial” amyloid is related to how it interacts with membranes , 2010, Prion.

[26]  P. Magistretti,et al.  Aβ42 Neurotoxicity Is Mediated by Ongoing Nucleated Polymerization Process Rather than by Discrete Aβ42 Species* , 2010, The Journal of Biological Chemistry.

[27]  S. Lindquist,et al.  Nucleated conformational conversion and the replication of conformational information by a prion determinant. , 2000, Science.

[28]  Françoise Immel,et al.  Screening for Toxic Amyloid in Yeast Exemplifies the Role of Alternative Pathway Responsible for Cytotoxicity , 2009, PloS one.

[29]  R. Kayed,et al.  Annular Protofibrils Are a Structurally and Functionally Distinct Type of Amyloid Oligomer* , 2009, Journal of Biological Chemistry.

[30]  A. Minton.  Implications of macromolecular crowding for protein assembly. , 2000, Current opinion in structural biology.

[31]  S. Lecomte,et al.  A yeast toxic mutant of HET-s((218-289)) prion displays alternative intermediates of amyloidogenesis. , 2010, Biophysical journal.

[32]  P. Hajduk,et al.  Structural characterization of a soluble amyloid beta-peptide oligomer. , 2009, Biochemistry.

[33]  R. Wickner,et al.  Prion diseases of yeast: amyloid structure and biology. , 2011, Seminars in cell & developmental biology.

[34]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[35]  L. Choo-Smith,et al.  Acceleration of Amyloid Fibril Formation by Specific Binding of Aβ-(1–40) Peptide to Ganglioside-containing Membrane Vesicles* , 1997, The Journal of Biological Chemistry.

[36]  N. Nevskaya,et al.  Infrared spectra and resonance interaction of amide‐I vibration of the antiparallel‐chain pleated sheet , 1976, Biopolymers.

[37]  R. D'Hooge,et al.  Lipids revert inert Aβ amyloid fibrils to neurotoxic protofibrils that affect learning in mice , 2007, The EMBO Journal.

[38]  Beat H. Meier,et al.  Amyloid Fibrils of the HET-s(218–289) Prion Form a β Solenoid with a Triangular Hydrophobic Core , 2008, Science.

[39]  Kenjiro Ono,et al.  Structure–neurotoxicity relationships of amyloid β-protein oligomers , 2009, Proceedings of the National Academy of Sciences.

[40]  P. Lansbury,et al.  Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? , 2006, Quarterly Reviews of Biophysics.

[41]  H. Lashuel,et al.  Amyloidogenic protein-membrane interactions: mechanistic insight from model systems. , 2010, Angewandte Chemie.

[42]  C. Dobson,et al.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.

[43]  Mark P. Mattson,et al.  40-residue D23N beta amyloid fibril , 2012 .

[44]  David Eisenberg,et al.  In Brief , 2009, Nature Reviews Neuroscience.

[45]  S. Lecomte,et al.  In vivo and in vitro analyses of toxic mutants of HET-s: FTIR antiparallel signature correlates with amyloid toxicity. , 2011, Journal of molecular biology.

[46]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[47]  M. Fändrich,et al.  Oligomeric and fibrillar species of β-amyloid (Aβ42) both impair mitochondrial function in P301L tau transgenic mice , 2008, Journal of Molecular Medicine.

[48]  Yves F Dufrêne,et al.  Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide. , 2009, The Biochemical journal.

[49]  S. Doglia,et al.  Conformational plasticity of the Gerstmann-Sträussler-Scheinker disease peptide as indicated by its multiple aggregation pathways. , 2008, Journal of molecular biology.

[50]  C. Sachse,et al.  Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Aβ protofibrils , 2007, Proceedings of the National Academy of Sciences.

[51]  Christopher M. Dobson,et al.  The Non-Core Regions of Human Lysozyme Amyloid Fibrils Influence Cytotoxicity , 2010, Journal of molecular biology.

[52]  D. Eisenberg,et al.  Toxic fibrillar oligomers of amyloid-β have cross-β structure , 2012, Proceedings of the National Academy of Sciences.

[53]  E. Goormaghtigh,et al.  Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel β-sheet structure. , 2012, The Biochemical journal.

[54]  R. Virchow.  Ueber eine im Gehirn und Rückenmark des Menschen aufgefundene Substanz mit der chemischen Reaction der Cellulose , 1854, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.

[55]  Y. Urade,et al.  A toxic monomeric conformer of the polyglutamine protein , 2007, Nature Structural &Molecular Biology.

[56]  Mark P Mattson,et al.  Antiparallel β-sheet architecture in Iowa-mutant β-amyloid fibrils , 2012, Proceedings of the National Academy of Sciences.

[57]  I. Alves,et al.  A yeast toxic mutant of HET-s amyloid disrupts membrane integrity. , 2012, Biochimica et biophysica acta.

[58]  Jie Li,et al.  The Association of α-Synuclein with Membranes Affects Bilayer Structure, Stability, and Fibril Formation* , 2003, Journal of Biological Chemistry.

[59]  C. Dobson,et al.  Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution , 2003, Journal of Molecular Medicine.

[60]  P. Lansbury,et al.  Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.